Sovaldi (sofosbuvir) is a direct-acting antiviral used to treat chronic hepatitis C virus (HCV) infection. It is a NS5B polymerase inhibitor that blocks a key enzyme the hepatitis C virus uses to copy its genetic material, stopping it from replicating.
Sofosbuvir is rarely used alone. It is the backbone of several combination regimens for hepatitis C, including:
In Australia, sofosbuvir is now more commonly available as part of the combination tablets Epclusa (sofosbuvir/velpatasvir) and Harvoni (ledipasvir/sofosbuvir), which treat a broader range of genotypes and are generally more convenient.
Back To Top
Take one 400 mg tablet once daily, with or without food. Take at the same time each day.
Sovaldi is always used in combination with other medicines. Do not use it alone for hepatitis C treatment.
Treatment duration depends on the genotype and regimen: typically 12 to 24 weeks.
Back To Top
If you remember within 18 hours of your usual dose, take it as soon as possible and resume your schedule. If more than 18 hours have passed, skip the dose and continue as usual. Never take two doses at once.
Back To Top
Contact your doctor or a poison control centre.
Back To Top
Side effects of Sovaldi are related to the sofosbuvir component and depend on the combination regimen used.
When used with ribavirin:
When used with peginterferon and ribavirin:
Your doctor will check blood counts and liver function during treatment. If you are using ribavirin, regular haemoglobin monitoring is essential.
Back To Top
Always tell all your doctors you are taking Sovaldi before starting any new medicine.
Back To TopCan Sovaldi cure hepatitis C on its own?
No. Sofosbuvir alone is not effective enough to cure hepatitis C. It must always be combined with at least one other direct-acting antiviral or with ribavirin. The high cure rates achieved with sofosbuvir-based regimens come from the combination of medicines working together to block multiple steps of the virus's replication cycle.
What is a sustained virological response?
A sustained virological response (SVR) means that no hepatitis C virus can be detected in your blood 12 weeks after completing treatment. SVR is considered a cure: for the vast majority of people, the virus does not return after achieving SVR. However, you can be re-infected with hepatitis C in the future if exposed again.
Back To Top
Ace provides accurate and independent information medically reviewed on prescription medications. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Back To Top